Targeting YAP for PDAC therapy
Targeting YAP for PDAC therapy. There are several strategies for targeting YAP in PDAC. Statin-mediated inhibition of HMG-CoA reductase in the mevalonate pathway reduces the geranylgeranylation and membrane localization of Rho GTPases, restricting YAP nuclear accumulation and thus its activity. Verteporfin and VGLL4-mimicking peptides disrupt the interaction between YAP and TEAD, inhibiting YAP-induced transcription. Metformin activates AMPK, which inhibits YAP both directly and by activating LATS kinases. BET inhibitors oppose the transcription of YAP-regulated genes. Neratinib increases the phosphorylation of LATS1 and YAP, causing YAP cytosolic accumulation and degradation.

Publication
YAP in pancreatic cancer: oncogenic role and therapeutic strategy. (2021) Wenhao Mao, et al. Theranostics. 2021;11(4):1753-1762. Figure: F5.Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
---|---|---|---|---|---|---|
Homo sapiens | Primates | SAV1 | SAV1 | ncbigene_symbol | SAV1 | 60485 |
Homo sapiens | Primates | MST1 | MST1 | ncbigene_symbol | MST1 | 4485 |
Homo sapiens | Primates | MST1 | MST1 | ncbigene_synonym | STK4 | 6789 |
Homo sapiens | Primates | MST1/2 | MST2 | ncbigene_synonym | STK3 | 6788 |
Homo sapiens | Primates | LATS1 | LATS1 | ncbigene_symbol | LATS1 | 9113 |
Homo sapiens | Primates | LATS1/2 | LATS2 | ncbigene_symbol | LATS2 | 26524 |
Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA1 | 5562 |
Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA2 | 5563 |
Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAB1 | 5564 |
Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAB2 | 5565 |
Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG1 | 5571 |
Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG2 | 51422 |
Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG3 | 53632 |
Homo sapiens | Primates | YAP | YAP | ncbigene_synonym | YAP1 | 10413 |
Homo sapiens | Primates | Rho | RHO | ncbigene_symbol | RHO | 6010 |
Homo sapiens | Primates | Rho | RHO | ncbigene_synonym | RHOD | 29984 |
Homo sapiens | Primates | Rho | RHO | famplex_relations | RHOA | 387 |
Homo sapiens | Primates | Rho | RHO | famplex_relations | RHOB | 388 |
Homo sapiens | Primates | Rho | RHO | famplex_relations | RHOC | 389 |
Homo sapiens | Primates | BET | BET | ncbigene_synonym | DNER | 92737 |
Homo sapiens | Primates | CTGF | CTGF | ncbigene_synonym | CCN2 | 1490 |
Homo sapiens | Primates | CYR61 | CYR61 | ncbigene_synonym | CCN1 | 3491 |
Homo sapiens | Primates | TEAD | TEAD | famplex_relations | TEAD1 | 7003 |
Homo sapiens | Primates | TEAD | TEAD | famplex_relations | TEAD2 | 8463 |
Homo sapiens | Primates | TEAD | TEAD | famplex_relations | TEAD3 | 7005 |
Homo sapiens | Primates | TEAD | TEAD | famplex_relations | TEAD4 | 7004 |
Danio rerio | Vertebrates | SAV1 | SAV1 | ncbigene_symbol | sav1 | 447821 |
Danio rerio | Vertebrates | MST1 | MST1 | ncbigene_symbol | mst1 | 259260 |
Danio rerio | Vertebrates | LATS1 | LATS1 | ncbigene_symbol | lats1 | 553164 |
Danio rerio | Vertebrates | LATS1/2 | LATS2 | ncbigene_symbol | lats2 | 567674 |
Danio rerio | Vertebrates | Rho | RHO | ncbigene_symbol | rho | 30295 |
Danio rerio | Vertebrates | Rho | RHO | ncbigene_synonym | rnd2 | 751645 |
Danio rerio | Vertebrates | CTGF | CTGF | ncbigene_synonym | ccn2a | 321449 |
Danio rerio | Vertebrates | CTGF | CTGF | ncbigene_synonym | ccn2b | 100124530 |
Danio rerio | Vertebrates | CYR61 | CYR61 | ncbigene_synonym | ccn1 | 403033 |
Danio rerio | Vertebrates | CYR61 | CYR61 | ncbigene_synonym | ccn1l2 | 553273 |
Word | Match | MeSH | Name | ChEBI |
---|---|---|---|---|
Mevalonate | NA | mesh:D008798 | ||
Statins | Simvastatin | mesh:D019821 | simvastatin | chebi:9150 |
Metformin | Metformin | mesh:D008687 | metformin | chebi:6801 |
Mevalonic acid | NA | mesh:D008798 | ||
Neratinib | neratinib | mesh:C487932 | neratinib | chebi:61397 |
Verteporfin | NA | mesh:C098350 |
Disease mentions
Word | Match | MeSH | Name | DOID |
---|